PD-Rx Pharmaceuticals, Inc. recalls Losartan Potassium USP, 50 mg, RX Only, Pkg By PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 60 Tablets
PD-Rx Pharmaceuticals recalls 50mg Losartan Potassium tablets due to trace NMBA contamination. Consumers should contact the company for details on affected lots and disposal instructions.
Recall notice
CGMP deviation: Product found to contain trace amounts of NMBA
Contact the company & request your remedy
What happened, in plain English
PD-Rx Pharmaceuticals is recalling 50mg Losartan Potassium tablets that may contain trace amounts of NMBA. This contamination could pose a health risk, though the specific danger level isn't clearly stated in the recall notice. Read more at govinfonow.com/recall/39118-pd-rx-losartan-potassium-50mg-recall-trace-nmba-contamination-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39118-pd-rx-losartan-potassium-50mg-recall-trace-nmba-contamination-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0341-2021
Cite this page
“PD-Rx Losartan Potassium 50mg Recall: Trace NMBA Contamination Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39118-pd-rx-losartan-potassium-50mg-recall-trace-nmba-contamination-risk. Based on FDA recall #D-0341-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0341-2021%22&limit=1).
Why it’s dangerous
The product was found to contain trace amounts of NMBA, a chemical that can be harmful when ingested. However, the recall notice does not specify the exact health risks or how severe they are.
Who’s affected
Prescription medication users who have the recalled Losartan Potassium tablets. Those with specific medical conditions or taking other medications may be at higher risk.
How to tell if you have this one
Check for the product name 'Losartan Potassium USP, 50 mg, RX Only' with the NDC codes 43063-854-60 or 43063-0854-90. The affected lots include A19B99, B19A26, B19A69, and others listed with expiration dates through November 2019.
- Brand
PD-Rx Pharmaceuticals- Category
Drug
What to do — step by step
Contact PD-Rx
Reach out to PD-Rx Pharmaceuticals for specific instructions on how to return or dispose of the affected tablets.
Questions people ask
Is this product safe to use?
The recall notice states the product may contain trace amounts of NMBA, but does not specify if it is safe to use.
What should I do if I have the recalled product?
Contact PD-Rx Pharmaceuticals for details on how to return or dispose of the affected tablets.
Are there any health risks from the trace NMBA?
The recall notice does not specify the health risks associated with the trace NMBA contamination.
Contact PD-Rx Pharmaceuticals
We’ve drafted a message you can send PD-Rx Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0341-2021 — PD-Rx Pharmaceuticals PD-Rx Pharmaceuticals Hello, I own a PD-Rx Pharmaceuticals that is covered by recall D-0341-2021 from PD-Rx Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0341-2021 (March 8, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0341-2021 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.